…and Boehringer Ingelheim’s broad drug discovery and clinical development capabilities. Aurobac has launched with €75 million in funding with Boehringer Ingelheim its lead investor. Official comments Werner Lanthaler, CEO of…

…team can now progress the candidate to clinical trials after the University’s commercialisation company UniQuest licensed the drug to the Brisbane start-up Infensa Bioscience for $23 million. The drug candidate,…

Drug discovery company MultiOmic Health and digital health start-up Mesh Bio will work together on an observational clinical study for patients with chronic metabolic disease and increased risk of complications…

News round-up by DDW’s Reece Armstrong for 27 – 30 June. Assays for monkeypox, Covid-19 boosters and approvals for oncology drugs are some of the themes of this week’s news…

…July 15:00PM BST will show how these tools are helping fundamentally alter our understanding of disease mechanisms, accelerating the discovery and development of novel therapeutics. Register for free here  …

…20 July 15:00 BST will show how these tools are helping fundamentally alter our understanding of disease mechanisms, accelerating the discovery and development of novel therapeutics. Register for free here…

…MND research. The MND-research partnership will now work together over three years to develop better tests to measure MND progression and that enables doctors to compare different drugs. It also…

…including an assessment of the next generation of stem cell derived products. You can also find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. Listen here…

…including an assessment of the next generation of stem cell derived products. You can also find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. Listen here…

…Championing female leaders across drug discovery and development: Improving quality control for CAR T cell therapies, plus exclusive interviews and articles on project management for drug development, synthetic biology, and…